You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0188 Efficacy and Safety of Add-on Treatment of Tacrolimus versus Leflunomide in Rheumatoid Arthritis Patients with Inadequate Response To Methotrexate: A 24-Week Double-Blinded Randomized Non-Inferiority Study

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - non-biologic treatment and small molecules
THU0188 Efficacy and Safety of Add-on Treatment of Tacrolimus versus Leflunomide in Rheumatoid Arthritis Patients with Inadequate Response To Methotrexate: A 24-Week Double-Blinded Randomized Non-Inferiority Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Shin K, Baek H, Kang Y, et al
THU0188 Efficacy and Safety of Add-on Treatment of Tacrolimus versus Leflunomide in Rheumatoid Arthritis Patients with Inadequate Response To Methotrexate: A 24-Week Double-Blinded Randomized Non-Inferiority Study
Annals of the Rheumatic Diseases 2016;75:253.